The IQMH office is closed to prevent the spread of COVID-19. We have moved to a virtual office. More info: IQMH Response to COVID-19.



Get industry news and event information sent to your inbox.
Job Ad Posting Service





Antimicrobial resistance in common hospital pathogens in Ontario: Annual Survey Report 2018

By Editor on 3/11/2020


Antimicrobial resistance poses a serious threat to patient safety and global public health, as current antimicrobials become less effective at treating resistant organisms. Health care-associated infections contribute to increased length of hospitalization, mortality and use of health care resources. In Canada, it is estimated that antimicrobial resistance causes 5,400 deaths and costs the health care system $1.4 billion per year.1 Patients colonized with antimicrobial resistant organisms (AROs) are a major reservoir for health care-associated pathogens; screening and surveillance programs further our understanding of the burden of AROs and the impact of infection control programs in health care settings. 

For nearly 20 years, the Institute for Quality Management in Healthcare (IQMH), formerly Quality Management Program—Laboratory Services (QMP–LS), administered an annual survey on antimicrobial resistance in common hospital pathogens to all licensed Ontario bacteriology laboratories and summarized the data in an annual report. In 2016, Public Health Ontario (PHO) and IQMH established a partnership to conduct an annual survey of AROs across all laboratories and hospitals for surveillance. As part of this collaboration, IQMH resumed laboratory survey administration, while PHO administered the hospital survey on infection control programs. Questions have evolved each year to capture the changing trends in AROs in Ontario. 

The 2018 survey was distributed to all licensed microbiology laboratories and all public hospitals in Ontario. Participants were surveyed on screening and infection control programs, as well as the prevalence of AROs: methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), extended spectrum beta-lactamases (ESBLs), carbapenemase-producing organisms (CPO) and Clostridioides difficile infections (CDI). 

The objective of this report is to summarize the findings of the annual survey on antimicrobial resistance of common hospital pathogens from 2018.   

Download the report.

Ontario Agency for Health Protection and Promotion (Public Health Ontario); Institute for Quality Management in Healthcare. Antimicrobial resistance in common hospital pathogens in Ontario: annual laboratory and hospital survey report 2018. Toronto, ON: Queen’s Printer for Ontario; 2020.

PHO and IQMH would like to thank those who participated in this 2018 survey and in the current 2019 survey which is due March 31, 2020. 


  1. Council of Canadian Academies. When Antibiotics Fail. Ottawa (ON): The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada, Council of Canadian Academies. [Internet]. 2019. Available from:


antimicrobial resistance
Centre for Proficiency Testing
Public Health Ontario


Institute for Quality
Management in Healthcare

1500-393 University Avenue
Toronto, Ontario Canada M5G 1E6





Get industry news and event information:SUBSCRIBE

Terms Of Use Privacy Statement © Copyright 2020 IQMH.